FULGENT GENETICS, INC. Cumulative Effect on Retained Earnings, before Tax (Deprecated 2020-01-31)
FULGENT GENETICS, INC. (FLGT) reported Cumulative Effect on Retained Earnings, before Tax (Deprecated 2020-01-31) of $327.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-13.
Discontinued › Notes › Equity
us-gaap:CumulativeEffectOnRetainedEarningsBeforeTax1 · last filed 2020-03-13
- FULGENT GENETICS, INC. cumulative effect on retained earnings, before tax (deprecated 2020-01-31) for the quarter ending 2018-12-31 was $0.00.
- FULGENT GENETICS, INC. cumulative effect on retained earnings, before tax (deprecated 2020-01-31) for the quarter ending 2018-09-30 was $0.00.
- FULGENT GENETICS, INC. cumulative effect on retained earnings, before tax (deprecated 2020-01-31) for the quarter ending 2018-06-30 was $0.00.
- FULGENT GENETICS, INC. cumulative effect on retained earnings, before tax (deprecated 2020-01-31) for the quarter ending 2018-03-31 was $327.00K.
- FULGENT GENETICS, INC. cumulative effect on retained earnings, before tax (deprecated 2020-01-31) for fiscal 2018 was $327.00K.
| Period end | Cumulative Effect on Retained Earnings, before Tax (Deprecated 2020-01-31) 3 month | Cumulative Effect on Retained Earnings, before Tax (Deprecated 2020-01-31) 6 month | Cumulative Effect on Retained Earnings, before Tax (Deprecated 2020-01-31) 9 month | Cumulative Effect on Retained Earnings, before Tax (Deprecated 2020-01-31) 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $0.00 derived: sum of 2 quarters · filed 2020-03-13 | $0.00 derived: sum of 3 quarters · filed 2020-03-13 | $327.00K 10-K · filed 2020-03-13 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2019-08-12 | $327.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $327.00K 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $327.00K 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |